Zosano Pharma Statistics Share Statistics Zosano Pharma has 0
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding n/a Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) n/a Shares Floating n/a Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 332.3K, so 0% of the outstanding
shares have been sold short.
Short Interest 332.3K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 4.68
Valuation Ratios The PE ratio is -1.75 and the forward
PE ratio is null.
Zosano Pharma's PEG ratio is
0.04.
PE Ratio -1.75 Forward PE n/a PS Ratio 67.1 Forward PS n/a PB Ratio 1.6 P/FCF Ratio -1.6 PEG Ratio 0.04
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Zosano Pharma.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.04,
with a Debt / Equity ratio of 0.29.
Current Ratio 1.04 Quick Ratio 1.04 Debt / Equity 0.29 Debt / EBITDA -0.34 Debt / FCF -0.29 Interest Coverage -157.33
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $19.63K Profits Per Employee $-752.85K Employee Count 40 Asset Turnover 0.02 Inventory Turnover n/a
Taxes Income Tax 189K Effective Tax Rate -0.63%
Stock Price Statistics The stock price has increased by 0.43% in the
last 52 weeks. The beta is 3.29, so Zosano Pharma's
price volatility has been higher than the market average.
Beta 3.29 52-Week Price Change 0.43% 50-Day Moving Average 1.58 200-Day Moving Average n/a Relative Strength Index (RSI) 26.22 Average Volume (20 Days) 5,363,116
Income Statement In the last 12 months, Zosano Pharma had revenue of 785K
and earned -30.11M
in profits. Earnings per share was -0.27.
Revenue 785K Gross Profit -11K Operating Income -29.74M Net Income -30.11M EBITDA -27.98M EBIT -29.74M Earnings Per Share (EPS) -0.27
Full Income Statement Balance Sheet The company has 11.04M in cash and 9.48M in
debt, giving a net cash position of 1.56M.
Cash & Cash Equivalents 11.04M Total Debt 9.48M Net Cash 1.56M Retained Earnings -362.12M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -27.59M
and capital expenditures -5.42M, giving a free cash flow of -33.01M.
Operating Cash Flow -27.59M Capital Expenditures -5.42M Free Cash Flow -33.01M FCF Per Share -0.29
Full Cash Flow Statement Margins Gross margin is -1.4%, with operating and profit margins of -3788.03% and -3836.18%.
Gross Margin -1.4% Operating Margin -3788.03% Pretax Margin -3812.1% Profit Margin -3836.18% EBITDA Margin -3564.97% EBIT Margin -3788.03% FCF Margin -4205.48%
Dividends & Yields ZSAN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ZSAN.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 12, 2022. It was a
backward
split with a ratio of 1:35.
Last Split Date Apr 12, 2022 Split Type backward Split Ratio 1:35
Scores Altman Z-Score n/a Piotroski F-Score n/a
